MicroRNAs in Skin Inflammation and Wounding by Mustard Vesicants.
MicroRNA 在皮肤炎症和芥末出疱剂造成的损伤中的作用。
基本信息
- 批准号:9974481
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-08 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAlkylating AgentsAutomobile DrivingBullaCell DeathChemical Warfare AgentsChronicCollagenComplexConditioned ReflexCutaneousCytokine SignalingDNA DamageDataDepositionDoseErythemaExposure toFGF2 geneFibrosisGene ExpressionGenesImmune responseImpaired wound healingInbred HRS MiceInflammationInflammatoryInflammatory ResponseInterleukin-1 betaInterleukinsLeadLesionMechlorethamineMediator of activation proteinMedicalMicroRNAsModelingMolecularMusMustardMustard GasOrganOutcomeOxidative StressPathologyPathway AnalysisPathway interactionsPigmentation physiologic functionPopulationQuality of lifeRNAReportingRoleSchemeSignal PathwaySkinSkin TissueSkin injurySkin wound healingTNF geneUlcerUntranslated RNAVascular Endothelial Growth FactorsVesicantsbasecytokinedesigndiagnostic biomarkernovel diagnosticsnovel markeroxidative damageprogramsresponseskin disorderskin lesiontargeted treatmentwoundwound healing
项目摘要
Sulfur mustard (SM), the most widely used chemical warfare agent, and nitrogen mustard (NM) are strong
alkylating agents causing DNA damage as well as oxidative damage leading to the activation of several
molecular pathways. After a latent period, their effect is an inflammatory response, epidermal cell death and
excruciating vesication and ulcerations in the skin tissue, which is the main target organ. Based on the
exposure dose and duration, these effects can lead to long-term skin complications like xerosis, erythema and
pigmentation changes with a long wound healing tenure causing medical burden and affecting the life quality.
There is plethora of information available on the skin pathology following exposure to vesicating agents;
however, the complex molecular mechanisms that lead to chronic skin lesions from acute exposures are still
debatable. Our completed studies in SKH-1 hairless mice have shown that acute cutaneous vesicant exposure
can lead to oxidative stress, DNA damage, activation of signaling pathways, and expression of inflammatory
and proteolytic mediators including cytokines, contributing to the skin inflammation, blister formation, and
delayed wound healing. Furthermore, we also found that NM-induced changes in MMP-9, inflammatory
cytokines like FGF2, TNF-α and IL-1β and VEGF in mouse skin were accompanied with alterations in micro-
RNAs miR-155, miR-203a and miR-21. Notably, these mi-RNAs are connected to chronic skin inflammation,
immune response and fibrosis (miR-155), cytokine signaling by targeting genes encoding pro-inflammatory
cytokines like TNF-α in the skin tissue (miR-203a) and skin wound healing and collagen deposition (miR-21).
This application is built upon these preliminary findings, and will investigate in detail the effect of SM and NM
exposure on miRNA changes in the skin tissue. Our hypothesis is that altered miRNAs related to
inflammation, wound healing and fibrosis could target the gene expression directing molecular
pathway alterations to cause chronic skin injury from vesicating agents’ exposure. Employing both NM-
and SM-induced skin tissues with chronic lesions in established mouse skin injury models, specific aims are: 1)
to determine miRNAs associated with inflammation, wound healing and fibrosis, and analyze miRNA targets as
well as related molecular pathways via miRNA target and pathway analysis programs; and 2) to confirm the
identified miRNA target molecules most relevant to vesicant-induced skin injury, and compare the outcomes
between both the NM- and SM-induced skin injuries. Completion of the proposed studies is anticipated to
identify unique miRNAs driving the molecular pathway alterations observed in SKH-1 hairless mice
following both SM- and NM-exposures. Outcomes are anticipated to establish miRNA signatures,
which can serve as novel diagnostic biomarkers and open a new avenue of miRNA-targeted treatment
of skin complications following SM and NM exposure.
使用最广泛的化学战剂硫芥(SM)和氮芥(NM)的毒性很强
烷化剂会造成 DNA 损伤以及氧化损伤,从而导致多种活性物质的激活
潜伏期后,它们的作用是炎症反应、表皮细胞死亡和
皮肤组织出现令人难以忍受的起泡和溃疡,这是主要的靶器官。
暴露剂量和持续时间,这些影响可能导致长期皮肤并发症,如干燥症、红斑和
色素沉着随着伤口愈合时间的延长而改变,造成医疗负担并影响生活质量。
有大量关于接触起泡剂后皮肤病理学的信息;
然而,由于急性暴露而导致慢性皮肤损伤的复杂分子机制仍然未知。
我们在 SKH-1 无毛小鼠中完成的研究表明,急性皮肤起疱剂暴露是有争议的。
可导致氧化应激、DNA 损伤、信号通路激活和炎症表达
和蛋白水解介质,包括细胞因子,导致皮肤炎症、水疱形成和
此外,我们还发现 NM 诱导 MMP-9、炎症的变化。
小鼠皮肤中的 FGF2、TNF-α、IL-1β 和 VEGF 等细胞因子伴随着微
RNA miR-155、miR-203a 和 miR-21 值得注意的是,这些 miRNA 与慢性皮肤炎症有关。
免疫反应和纤维化 (miR-155),通过靶向编码促炎基因的细胞因子信号转导
皮肤组织中的细胞因子如 TNF-α (miR-203a) 以及皮肤伤口愈合和胶原蛋白沉积 (miR-21)。
该应用程序建立在这些初步发现的基础上,并将详细研究 SM 和 NM 的效果
我们的假设是 miRNA 与皮肤组织中的 miRNA 变化有关。
炎症、伤口愈合和纤维化可以靶向基因表达指导分子
使用 NM- 导致慢性皮肤损伤的途径改变。
以及在已建立的小鼠皮肤损伤模型中SM诱导的皮肤组织出现慢性病变,具体目标是:1)
确定与炎症、伤口愈合和纤维化相关的 miRNA,并分析 miRNA 靶标
以及通过 miRNA 靶标和通路分析程序确定相关分子通路;2) 确认
确定了与起疱剂引起的皮肤损伤最相关的 miRNA 靶分子,并比较了结果
NM 和 SM 引起的皮肤损伤之间的关系预计将完成拟议的研究。
鉴定驱动 SKH-1 无毛小鼠中观察到的分子通路改变的独特 miRNA
SM 和 NM 暴露后的结果预计会建立 miRNA 特征,
可以作为新型诊断生物标志物并开辟 miRNA 靶向治疗的新途径
SM 和 NM 暴露后的皮肤并发症。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Deciphering the role of microRNAs in mustard gas-induced toxicity.
- DOI:10.1111/nyas.14539
- 发表时间:2021-05
- 期刊:
- 影响因子:5.2
- 作者:Mishra N;Raina K;Agarwal R
- 通讯作者:Agarwal R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajesh Agarwal其他文献
Rajesh Agarwal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajesh Agarwal', 18)}}的其他基金
Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.
地塞米松是治疗眼部损伤的有效疗法。
- 批准号:
10220981 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.
地塞米松是治疗眼部损伤的有效疗法。
- 批准号:
10472580 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
苦瓜汁抗胰腺癌的分子机制。
- 批准号:
9326951 - 财政年份:2014
- 资助金额:
$ 23.33万 - 项目类别:
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
苦瓜汁抗胰腺癌的分子机制。
- 批准号:
9128577 - 财政年份:2014
- 资助金额:
$ 23.33万 - 项目类别:
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
苦瓜汁抗胰腺癌的分子机制。
- 批准号:
8629506 - 财政年份:2014
- 资助金额:
$ 23.33万 - 项目类别:
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
苦瓜汁抗胰腺癌的分子机制。
- 批准号:
9563978 - 财政年份:2014
- 资助金额:
$ 23.33万 - 项目类别:
Effective Therapies for Ocular Injuries by Vesicating Agents
起泡剂治疗眼损伤的有效方法
- 批准号:
8726411 - 财政年份:2012
- 资助金额:
$ 23.33万 - 项目类别:
Effective Therapies for Ocular Injuries by Vesicating Agents
起泡剂治疗眼损伤的有效方法
- 批准号:
9139458 - 财政年份:2012
- 资助金额:
$ 23.33万 - 项目类别:
Effective Therapies for Ocular Injuries by Vesicating Agents
起泡剂治疗眼损伤的有效方法
- 批准号:
8333167 - 财政年份:2012
- 资助金额:
$ 23.33万 - 项目类别:
Effective Therapies for Ocular Injuries by Vesicating Agents
起泡剂治疗眼损伤的有效方法
- 批准号:
8927642 - 财政年份:2012
- 资助金额:
$ 23.33万 - 项目类别:
相似国自然基金
TiC-TiB2颗粒喷射成形原位合成及其对M2高速工具钢共晶碳化物形成与演化的影响
- 批准号:52361020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
植被群落演替对河道水流结构和纵向离散特性影响机制研究
- 批准号:52309088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带印度洋海表皮温日变化的数值模拟及对海气热通量的影响
- 批准号:42376002
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
协同遥感和气候模型的城市高温热浪时空特征及其对热暴露影响研究
- 批准号:42371397
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
Mechanistic Understanding of Mustard Gas Toxicity in the Retina using a Minipig Model
使用小型猪模型了解芥子气视网膜毒性的机制
- 批准号:
10882080 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
- 批准号:
10438061 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
- 批准号:
10580070 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard
涡轮滴眼液治疗硫芥引起的眼部毒性和失明
- 批准号:
10673584 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard
涡轮滴眼液治疗硫芥引起的眼部毒性和失明
- 批准号:
10015700 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别: